Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine
Crossref DOI link: https://doi.org/10.1007/s13346-021-00911-y
Published Online: 2021-01-29
Published Print: 2021-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Milane, Lara
Amiji, Mansoor
Text and Data Mining valid from 2021-01-29
Version of Record valid from 2021-01-29
Article History
Accepted: 15 January 2021
First Online: 29 January 2021
Free to read: This content has been made available to all.